Epidemiology and molecular characterization of nosocomially transmitted multidrug-resistant Klebsiella pneumoniae

N Parasakthi1, J Vadivelu, H Ariffin

  • 1Department of Medical Microbiology, University of Malaya Medical Centre, Kuala Lumpur, Malaysia. parasak@medicine.med.um.edu.my

Abstract

Insights

This study investigated a multidrug-resistant Klebsiella pneumoniae outbreak in a pediatric oncology unit. The outbreak was controlled by reinforcing infection control and addressing environmental contamination, not clonal spread.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Epidemiology

Background:

  • Nosocomial outbreaks of multidrug-resistant Klebsiella pneumoniae (MRKP) pose significant threats in healthcare settings, particularly in immunocompromised populations.
  • Pediatric oncology units are vulnerable to healthcare-associated infections due to patients' weakened immune systems.

Purpose of the Study:

  • To investigate the epidemiology, antimicrobial susceptibility, genomic profiles, and control measures of a nosocomial MRKP outbreak.
  • To identify the source and transmission dynamics of MRKP within a pediatric oncology ward.

Main Methods:

  • Prospective epidemiologic and microbiologic study of MRKP isolates from patients and environmental samples.
  • Antimicrobial susceptibility testing, plasmid analysis, and pulsed-field gel electrophoresis (PFGE) for genomic profiling.

Main Results:

  • MRKP isolates were resistant to ceftazidime, sensitive to imipenem and ciprofloxacin, and were extended-spectrum beta-lactamase (ESBL) producers.
  • PFGE analysis revealed six distinct DNA profiles (A-F), indicating the outbreak strains were not clonal in origin.
  • Common large plasmids (80-100 kb) were found in eight isolates, suggesting potential for horizontal gene transfer.

Conclusions:

  • The MRKP outbreak strains were not clonally related, implying multiple introductions or diverse sources.
  • The successful control of the outbreak was attributed to the reemphasis of standard infection control procedures.
  • Implementing a program to address environmental contamination was crucial in curbing the spread of MRKP.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...